Pfizer Inc.
Toll-like receptor agonists
Last updated:
Abstract:
The present invention relates to imidazo-pyridinyl compounds, or a pharmaceutically acceptable salt thereof, to pharmaceutical compositions comprising such compounds and salts, and to methods of using such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer, in a subject.
Status:
Grant
Type:
Utility
Filling date:
13 Jul 2020
Issue date:
24 May 2022